Levator palpebrae inhibition < Levodopa < Levodopa hyporesponsive

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 64.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000030 (1997)	Larsen [Norvège] ; Jette Boas [Danemark]	The effects of early selegiline therapy on long‐term levodopa treatment and parkinsonian disability: An interim analysis of a norwegian–danish 5‐year study
000060 (1998)	Han L. Ryoo [États-Unis] ; Dylan Pierrotti [États-Unis] ; Joyce [États-Unis]	Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease
000166 (1998)	Morris ; Robert Iansek ; Thomas Matyas ; Jeffery Summers [Australie]	Abnormalities in the stride length‐cadence relation in parkinsonian gait
000261 (2000)	Donato A. Di Monte [États-Unis] ; Alison Mccormack [États-Unis, Suède] ; Giselle Petzinger [États-Unis] ; Ann Marie Janson [États-Unis, Suède] ; Maryka Quik [États-Unis] ; William J. Langston [États-Unis]	Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model
000315 (1997)	Anne Burleigh-Jacobs [États-Unis] ; Horak [États-Unis] ; John G. Nutt [États-Unis] ; Jose A. Obeso [Espagne]	Step initiation in Parkinson's disease: Influence of levodopa and external sensory triggers
000429 (2000)	Jaime Kulisevsky [Espagne] ; Carmen García-Sánchez [Espagne] ; Marcelo L. Berthier [Espagne] ; Manel Barbanoj [Espagne] ; Berta Pascual-Sedano [Espagne] ; Alexandre Gironell [Espagne] ; Armando Estévez-González [Espagne]	Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: A two‐year follow‐up study of previously untreated patients
000585 (1998)	John D. O'Sullivan [Australie] ; Catherine M. Said [Australie] ; Louise C. Dillon [Australie] ; Marion Hoffman [Australie] ; Hughes [Australie]	Gait analysis in patients with Parkinson's disease and motor fluctuations: Influence of levodopa and comparison with other measures of motor function
000674 (1994)	Roberto Marconi [France, Italie] ; Dominique Lefebvre-Caparros [France] ; Anne-Marie Bonnet [France] ; Marie Vidailhet [France] ; Bruno Dubois [France] ; Agid [France]	Levodopa‐induced dyskinesias in Parkinson's disease phenomenology and pathophysiology
000A07 (1997)	John G. Nutt [États-Unis] ; Julie H. Carter [États-Unis] ; Eric S. Lea [États-Unis] ; William R. Woodward [États-Unis]	Motor fluctuations during continuous levodopa infusions in patients with Parkinson's disease
000B51 (1997)	Lance A. Smith ; Ariel Gordin ; Jenner [Finlande] ; C. David Marsden [Royaume-Uni]	Entacapone enhances levodopa‐induced reversal of motor disability in MPTP‐treated common marmosets
000B83 (2000)	I. Reuter [Royaume-Uni] ; S. Harder [Allemagne] ; M. Engelhardt [Allemagne] ; H. Baas [Allemagne]	The effect of exercise on pharmacokinetics and pharmacodynamics of levodopa
000B91 (1998)	Rascol [France] ; David J. Brooks [Royaume-Uni] ; Ehrout R. Brunt [Pays-Bas] ; Amos D. Korczyn [Israël] ; Warner H. Poewe [Autriche] ; Fabrizzio Stocchi [Italie]	Ropinirole in the treatment of early Parkinson's disease: A 6‐month interim report of a 5‐year levodopa‐controlled study
001329 (1997)	Rajput [Canada] ; M. E. Fenton [Canada] ; S. Birdi [Canada] ; R. Macaulay [Canada]	Is levodopa toxic to human substantia nigra?
001349 (1996)	Roos [Pays-Bas] ; J. C. F. Jongen [Pays-Bas] ; E. A. Van Der Velde [Pays-Bas]	Clinical course of patients with idiopathic Parkinson's disease
001389 (2000)	Christopher G. Goetz [États-Unis] ; Glenn T. Stebbins [États-Unis] ; Lucy M. Blasucci [États-Unis]	Differential progression of motor impairment in levodopa‐treated Parkinson's disease
001400 (1995)	Przedborski [États-Unis] ; Vernice Jackson-Lewis [États-Unis] ; Stanley Fahn [États-Unis]	Antiparkinsonian therapies and brain mitochondrial complex I activity
001414 (1999)	Jeffery Kimber [Royaume-Uni] ; Laura Watson [Royaume-Uni] ; Christopher J. Mathias [Royaume-Uni]	Neuroendocrine responses to levodopa in multiple system atrophy (MSA)
001422 (1998)	Neill R. Hughes [Royaume-Uni] ; Alexander T. Mcknight [Royaume-Uni] ; Geoffrey N. Woodruff [Royaume-Uni] ; Michael P. Hill [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Brotchie [Royaume-Uni]	Kappa‐opioid receptor agonists increase locomotor activity in the monoamine‐depleted rat model of parkinsonism
001524 (1994)	Olanow [États-Unis] ; S. Fahn [États-Unis] ; M. Muenter [États-Unis] ; H. Klawans [États-Unis] ; H. Hurtig [États-Unis] ; M. Stern [États-Unis] ; I. Shoulson [États-Unis] ; R. Kurlan [États-Unis] ; J. D. Grimes [Canada] ; J. Jankovic [États-Unis] ; M. Hoehn [États-Unis] ; C. H. Markham [États-Unis] ; R. Duvisin [États-Unis] ; O. Reinmuth [États-Unis] ; H. A. Leonard [États-Unis] ; E. Ahlskog [États-Unis] ; R. Feldman [États-Unis] ; L. Hershey [États-Unis] ; M. D. Yahr [États-Unis]	A multicenter double‐blind placebo‐controlled trial of pergolide as an adjunct to sinemet® in Parkinson's disease
001592 (1992)	María Angeles Mena ; Beatriz Pardo ; María José Casarejos ; Stanley Fahn [États-Unis] ; Justo García De Yébenes [Espagne]	Neurotoxicity of levodopa on catecholamine‐rich neurons
001686 (1999)	William J. Weiner [États-Unis]	The initial treatment of Parkinson's disease should begin with levodopa

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/KwdEn.i -k "Levodopa" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/KwdEn.i  \
                -Sk "Levodopa" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Levodopa
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024